| E |
| Eades T. |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| Eap C. |
- |
FREQUENCIES OF CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5, MDR1 ALLELIC VARIANTS IN PATIENTS WITH DIFFERENT ACENOCOUMAROL DOSE REQUIREMENTS |
| Earhart A.D. |
- |
GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN |
| Earthrowl M. |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| Ebenezer C. |
- |
ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA? |
| Eberl W. |
- |
DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID |
| |
- |
VARIABILITY IN PERFORMING PLATELET AGGREGOMETRY FOR DIAGNOSIS OF INBORN DISORDERS OF PLATELET FUNCTION IN GERMANY, AUSTRIA AND SWITZERLAND |
| Eberle S. |
- |
DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY |
| Ebinuma H. |
- |
NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN |
| Eble J.A. |
- |
THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS |
| Echart C. |
- |
DEFIBROTIDE DIRECTLY ENHANCE THE ACTIVITY OF PLASMIN |
| |
- |
DEFIBROTIDE PROTECTS ENDOTHELIAL CELLS AGAINST STRESS-INDUCED CELL DEATH VIA INHIBITION OF THE EXTRINSIC APOPTOSIS PATHWAY |
| |
- |
DEFIBROTIDE MODULATES HEPARANASE EXPRESSION IN ENDOTHELIAL AND TUMOR CELLS: A POTENTIAL MECHANISM OF ACTION |
| Echevarria G. |
- |
THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY |
| Eckly A. |
- |
VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES |
| |
- |
MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES |
| |
- |
ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME |
| |
- |
MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES |
| Eckmann C. |
- |
THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY |
| |
- |
CORRELATION BETWEEN THE POTENCY OF A BETA2-GLYCOPROTEIN I DEPENDENT LUPUS ANTICOAGULANT AND THE LEVEL OF RESISTANCE TO ACTIVATED PROTEIN C |
| Eder B. |
- |
PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY |
| Édes I. |
- |
ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN |
| |
- |
MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION |
| Edlund M. |
- |
DALTEPARIN SHORTENS HUMAN LABOR |
| Edvardsson N. |
- |
ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE |
| Edwards R.M. |
- |
PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN |
| Edwards A. |
- |
OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM |
| Eelde A. |
- |
INCREASED FIBRINOLYISIS ASSOCIATED WITH DEFECTIVE COAGULATION CONTRIBUTES TO IMPAIRMENT OF HEMOSTASIS IN HEMOPHILIA |
| Egan H. |
- |
RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT |
| Egawa N. |
- |
INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS |
| Egberg N. |
- |
PREANALYTICAL CONDITIONS INFLUENCING FLOW CYTOMETRIC DETERMINATION OF PLATELET-DERIVED MICROPARTICLES (PDMP) |
| |
- |
THE EXPRESSION OF PLATELET RECEPTORS AND MARKERS OF PLATELET ACTIVATION IN PATIENTS WITH HEMOPHILIA A AND VON WILLEBRANDS DISEASE |
| Egin Y. |
- |
SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS |
| Eglite J. |
- |
NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA |
| Egorina E. |
- |
DETERMINATION OF TISSUE FACTOR ORIGIN USING SIRNA KNOCKDOWN APPROACH IN HUMAN PERIPHERAL BLOOD WHITE CELLS |
| Egorova E. |
- |
D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS |
| Egrilmez M. |
- |
ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS |
| Eguchi Y. |
- |
EFFICACY OF ANTI-COAGULATION AND ANTI-INFLAMATORY THERAPY FOR SEVERE SEPSIS |
| |
- |
THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS |
| Ehlen M. |
- |
CATHETER-RELATED THROMBOSES IN NEWBORNS |
| Ehm M. |
- |
QUANTITATION OF D-DIMER BY LOCI TECHNOLOGY |
| Ehrlich Y.H. |
- |
THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES |
| Ehrlich H. |
- |
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION |
| |
- |
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT |
| Eichelberger B. |
- |
PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA |
| Eichinger S. |
- |
RECURRENT VENOUS THROMBOEMBOLISM LINKED TO LOW PLASMA HDL |
| |
- |
6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS |
| |
- |
SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP |
| |
- |
MICROPARTICLES IN THROMBIN GENERATION - A SIGNIFICANT PARAMETER INFLUENCING PEAK THROMBIN LEVELS |
| |
- |
CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES |
| |
- |
EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII |
| |
- |
EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM |
| |
- |
CIRCULATING P-SELECTIN AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM |
| |
- |
EMOTIONAL IMPLICATIONS OF GENETIC TESTING AND ASPECTS OF COUNSELLING IN WOMEN PRIOR ORAL CONTRACEPTIVE INTAKE |
| |
- |
ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH) |
| Eichler P. |
- |
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS |
| |
- |
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS |
| Eid S.S. |
- |
INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY |
| Eidher U. |
- |
LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS |
| Eigenthaler M. |
- |
HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION |
| Eijsman L. |
- |
RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS |
| Eikelboom J. |
- |
CLINICAL EFFICACY AND SAFETY OF FONDAPARINUX IN PATIENTS WITH CONGESTIVE HEART FAILURE (CHF): A SUBANALYSIS OF THE RANDOMIZED ARTEMIS TRIAL |
| |
- |
EFFECT OF FONDAPARINUX 2.5 MG ONCE DAILY ON ALL CAUSE MORTALITY: A META-ANALYSIS OF THROMBOPROPHYLAXIS TRIALS |
| |
- |
EFFICACY OF FONDAPARINUX IN MEDICAL PATIENTS WITH RESTRICTED MOBILITY ACCORDING TO THE ENDPOINT PROPOSED BY THE EUROPEAN COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) |
| Eikelboom J.W. |
- |
LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS |
| |
- |
ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW |
| |
- |
COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD) |
| |
- |
CLINICAL FACTORS INFLUENCING THE SENSITIVITY TO WARFARIN WHEN RESTARTED AFTER SURGERY |
| |
- |
COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYDRO THROMBOXANE B2 |
| |
- |
COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYRO THROMBOXANE B2 |
| |
- |
COMBINED ANTIPLATELET AND ANTICOAGULANT THERAPY: CLINICAL BENEFITS AND RISKS |
| Eikenboom J. |
- |
BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY |
| Eikenboom J.C. |
- |
THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY |
| Eikenboom J. |
- |
RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD) |
| Eikenboom J.C.J. |
- |
ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS) |
| |
- |
CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS |
| |
- |
LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS |
| |
- |
AQUAPORIN 2 GENE VARIATIONS, LEVELS OF VON WILLEBRAND FACTOR AND FACTOR VIII AND THE RISK OF VENOUS THROMBOSIS |
| Eikenboom J.J. |
- |
HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES |
| Eikenboom J.C.J. |
- |
FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS |
| Eilertsen A.L. |
- |
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) POLYMORPHISMS, HORMONE REPLACEMENT THERAPY (HRT) AND RISK OF VENOUS THROMBOEMBOLISM (VTE) |
| |
- |
DIFFERENTIAL EFFECTS OF CONVENTIONAL AND LOW DOSE ORAL HORMONE THERAPY, TIBOLONE AND RALOXIFENE ON FUNCTIONALITY OF THE ACTIVATED PROTEIN C SYSTEM |
| |
- |
DIFFERENTIAL EFFECTS OF CONVENTIONAL DOSE HORMONE THERAPY, LOW DOSE HT, TIBOLONE AND RALOXIFENE ON C-REACTIVE PROTEIN AND OTHER INFLAMMATORY MARKERS |
| Einarsdottir K.A. |
- |
WARFARIN ANTICOAGULATION INTENSITY IN SPECIALIST-BASED AND IN COMPUTER -ASSISTED DOSING PRACTICE |
| Einav Y. |
- |
TESTING AGONIST-INDUCED PLATELET AGGREGATION BY THE IMPACT-R |
| Eischer L. |
- |
SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP |
| |
- |
6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS |
| Eisenberg P.R. |
- |
SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS |
| Eisenberg P. |
- |
EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT) |
| Eisenhardt S.U. |
- |
A NOVEL SINGLE-CHAIN (SCFV) ANTIBODY PHAGE-DISPLAY STRATEGY FOR THE DEVELOPMENT OF POTENTIAL ANTI-ATHEROSCLEROTIC DRUGS |
| |
- |
MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS |
| Eisenhut Y. |
- |
BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY |
| Eisert R.M. |
- |
SUCCESSFUL TREATMENT OF PATIENTS WITH INHIBITORS TO COAGULATION FACTOR VIII AND IX BY TREATING CONCOMITANT HEPATITIS C |
| Eissner G. |
- |
DEFIBROTIDE PROTECTS ENDOTHELIAL CELLS AGAINST STRESS-INDUCED CELL DEATH VIA INHIBITION OF THE EXTRINSIC APOPTOSIS PATHWAY |
| Ekdal H.D. |
- |
SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF) |
| Ekholm M. |
- |
DOES ANGIOTENSIN II HAVE PROINFLAMMATORY OR PROTHROMBOTIC EFFECTS? |
| Ekman M. |
- |
THE CAPACITY TO GENERATE THROMBIN IN FACTOR VIII INHIBITOR PLASMAS DIFFERS AMONG COMMERCIAL CONCENTRATES AND IS ASSOCIATED WITH VON WILLEBRAND FACTOR CONTENT. IS THIS OF IMPORTANCE FOR ITI SUCCESS? |
| Ekman-Ordeberg G. |
- |
DALTEPARIN SHORTENS HUMAN LABOR |
| Ekuklu G. |
- |
THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL |
| El Aly M. |
- |
HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL |
| El Benna J. |
- |
MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION |
| el Bouazzaoui B. |
- |
CLINICAL FACTORS INFLUENCING THE SENSITIVITY TO WARFARIN WHEN RESTARTED AFTER SURGERY |
| El Eter E. |
- |
ROLE OF THYROID HORMONE ANALOGS IN ANGIOGENESIS AND THE DEVELOPMENT OF COLLATERALS IN RABBIT HIND LIMB ISCHEMIA MODEL |
| El Naggar A.I. |
- |
PROTHROMBIN AND FACTOR V LEIDEN GENE POLYMORPHISM IN PATIENTS WITH DVT |
| El Nemer W. |
- |
INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM |
| El Rouby S. |
- |
EVALUATION OF THE POINT OF CARE MICRO-COAGULATION TESTS IN PEDIATRICS |
| |
- |
MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS |
| Elalamy I. |
- |
IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION |
| |
- |
INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA |
| |
- |
ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| |
- |
THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE |
| |
- |
BRIDGING THERAPY IN PATIENTS TREATED WITH LMWH AND COUMARIN INDUCES DEEP INHIBITION OF THROMBIN GENERATION |
| |
- |
D-DIMER MEASUREMENT AND THROMBOPHILIA SCREENING IN THE FOLLOW-UP OF PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM |
| |
- |
HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE |
| Elbaz S. |
- |
IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA |
| Elbaz O. |
- |
PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA |
| Elbazi R. |
- |
CLINICAL FACTORS INFLUENCING RETURN TO NORMAL HEMOSTASIS AFTER STOPPING WARFARIN |
| El-Demery A. |
- |
PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA |
| Elder J. |
- |
HEPARIN EYE DROPS ARE EFFECTIVE AS LONG TERM THERAPY FOR LIGNEOUS CONJUNCTIVITIS |
| El-Ekiaby M. |
- |
TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA |
| Elezovic I. |
- |
MOLECULAR MARKERS OF BLOOD HYPERCOAGULABILITY IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN MUTATION |
| Elezovic I.V. |
- |
EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION |
| Elf J. |
- |
CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH |
| |
- |
CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH |
| |
- |
EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM |
| Elg M. |
- |
THE EFFECT OF DIRECT THROMBIN INHIBITORS (DTIS) IN CLOTTING PLASMA |
| |
- |
THE ANTITHROMBOTIC EFFECT OF AR-H067637, THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS |
| |
- |
THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL |
| Elgue G. |
- |
FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS |
| |
- |
ACTIVATION OF BLOOD COAGULATION IN AB0-COMPATIBLE BLOOD BY MULTIPOTENT MESENCHYMAL STROMAL CELLS |
| Elias P. |
- |
THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) |
| Eligini S. |
- |
PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY |
| |
- |
CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS |
| |
- |
PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1 |
| Eller P. |
- |
UNEXPLAINED HIGH D-DIMER |
| Eller T. |
- |
ESTABLISHING REFERENCE VALUES FOR COAGULATION PARAMETERS IN PREGNANT WOMEN |
| Ellingsen D. |
- |
THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY |
| Ellis P. |
- |
DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME |
| |
- |
MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY |
| Ellison S.M. |
- |
CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS |
| |
- |
CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI |
| Elm T. |
- |
WHOLE BLOOD CLOTTING TIME (WBCT) COMPARED TO IN VIVO DOSE RESPONSE OF RFVIIA IN FVIII-KO MICE |
| El-Menshawi N. |
- |
PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA |
| Elvers M. |
- |
COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO |
| |
- |
DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION |
| |
- |
RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS |
| |
- |
RHOA IS ESSENTIAL FOR MEGAKARYOCYTE SURVIVAL IN VIVO |
| Emelyanova A.N. |
- |
CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION |
| Emery N. |
- |
LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS |
| |
- |
PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS |
| Emiliani C. |
- |
BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV |
| Emmerich J. |
- |
AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS |
| |
- |
EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY |
| |
- |
EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS) |
| |
- |
A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES |
| |
- |
PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE) |
| |
- |
BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA |
| |
- |
COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC |
| Emmi V. |
- |
EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS |
| |
- |
LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM |
| Emonts M. |
- |
ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS |
| Emsley J. |
- |
MOLECULAR MODEL OF THE PREKALLEKREIN STRUCTURE |
| Enayat M.S. |
- |
A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES |
| |
- |
HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK |
| |
- |
A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND |
| |
- |
GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS |
| Enayat M. |
- |
FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY |
| Enders G. |
- |
IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB |
| Endo S. |
- |
THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS |
| Endo M. |
- |
OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL |
| Endres J.L. |
- |
CORRELATIONS BETWEEN ADAMTS13 ACTIVITY AND INHIBITOR LEVELS: OBSERVATIONS AND IMPLICATIONS FOR RESOURCE UTILIZATION |
| Enea I. |
- |
EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY |
| Engel H. |
- |
NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS |
| Engelborghs Y. |
- |
BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT |
| Engelmann B. |
- |
PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY |
| |
- |
BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION |
| Engelmann L. |
- |
INHIBITOR AGAINST F V MONTORING WITH THROMBIN GENERATION ASSAYS |
| |
- |
MONITORING NOVOSEVEN THERAPY WITH DIFFERENT METHODS |
| Engelsen J. |
- |
COMPARISON OF INTERNATIONAL NORMALIZED RATIOS (INRS) DETERMINED BY INRATIO AND COAGU-CHEK XS WITH PLASMA-BASED LABORATORY INR: INFLUENCE OF LUPUS ANTICOAGULANTS |
| Englund A. |
- |
ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE |
| Enjeti A.K. |
- |
PREANALYTICAL VARIABLES IN THE FLOW CYTOMETRIC ANALYSIS OF MICROPARTICLES |
| Ennamany R. |
- |
BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES |
| |
- |
SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION |
| Ennezat P. |
- |
METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES |
| Enockson C. |
- |
PRIMARY HUMAN SYNOVIAL CELLS PROLIFERATE IN RESPONSE TO HEMOGLOBIN AND WHOLE BLOOD |
| Enouf J. |
- |
CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS |
| Enslen H. |
- |
CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA |
| Enström C. |
- |
PLASMA S/R RATIO OF WARFARIN CO-VARIES WITH VKORC1 HAPLOTYPE |
| Epstein J. |
- |
IMPROVING RECOMBINANT FACTOR VIII (RFVIII) DOSING PRECISION IN THE TREATMENT OF HEMOPHILIA A RESULTS IN POTENTIAL COST SAVINGS |
| Erba G. |
- |
FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM |
| Erbe M. |
- |
ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS |
| |
- |
MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM |
| |
- |
ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS? |
| Erdogan E. |
- |
ALLOSTERIC REGULATION OF PROTHROMBIN ACTIVATION BY FACTOR VA |
| Ericsson C. |
- |
ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION |
| Eriksen M. |
- |
CARDIAC tPA RELEASE DURING SYMPATHETIC NERVE STIMULATION IN PIGS DECREASES BY REPEATED STIMULATIONS |
| Eriksson B.I. |
- |
ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW |
| |
- |
LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY |
| |
- |
PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF RIVAROXABAN: A COMPARISON OF ONCE- AND TWICE-DAILY DOSING IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT (THR) |
| |
- |
PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION |
| |
- |
DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT |
| |
- |
THE ORAL DIRECT THROMBIN INHIBITOR, DABIGATRAN ETEXILATE, IS EFFECTIVE AND SAFE FOR PREVENTION OF MAJOR VENOUS THROMBOEMBOLISM FOLLOWING MAJOR ORTHOPEDIC SURGERY |
| Eriksson H. |
- |
CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS |
| Eriksson-Lepkowska M. |
- |
CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS |
| Erlinge D. |
- |
GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE |
| |
- |
GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE |
| Ersoy M. |
- |
PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS |
| Ertl G. |
- |
HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION |
| Erwich J.H.M. |
- |
THROMBIN ACTIVATBLE FIBRINOLYSIS INHIBITOR (TAFI) IS NOT ASSOCIATED WITH FETAL LOSS; A RETROSPECTIVE STUDY |
| Erwin H. |
- |
ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC |
| Esaiasen E. |
- |
THE PREDICTIVE VALUE OF CRP, D-DIMER AND CLINICAL PROBABILITY TO EXCLUDE DVT IN PERSONS ADMITTED TO HOSPITAL FOR DVT |
| Eschwège V. |
- |
A SCREENING TEST FOR THROMBOSIS RISK FACTORS AS A MARKER OF LIVER FIBROSIS IN CHRONIC HEPATITIS C |
| |
- |
A NEW MODE OF PROTHROMBIN TIME (PT) REPORTING SPECIFIC FOR LIVER DISEASES |
| Escobar M. |
- |
SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE |
| Escobar M.A. |
- |
A COVALENT REACTIVE ANTIGEN ANALOG TO FACTOR VIII REDUCES ANTIBODY PRODUCTION IN MEMORY B CELLS AFTER RE-STIMULATION WITH FVIII |
| |
- |
FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION |
| Escolar G. |
- |
ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN |
| |
- |
FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA |
| |
- |
SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK |
| |
- |
ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| |
- |
INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION |
| |
- |
SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR |
| Escuriola C. |
- |
DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID |
| Escuriola Ettingshausen C. |
- |
EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN |
| Escuriola-Ettingshausen C. |
- |
SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE |
| Eshghi P. |
- |
GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS |
| Eskiocak M. |
- |
LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS |
| Esmon C.T. |
- |
ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER |
| |
- |
AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS |
| |
- |
ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE |
| Esmon P. |
- |
SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY |
| Esmon C.T. |
- |
PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC |
| Esmon N.L. |
- |
PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC |
| Esmon C.T. |
- |
ENDOTHELIAL PROTEIN C RECEPTOR |
| España F. |
- |
PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION |
| |
- |
ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION |
| |
- |
INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE |
| |
- |
INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS |
| |
- |
ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION |
| |
- |
FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS |
| |
- |
FUNCTIONAL ANALYSIS OF SNPS SPECIFIC FOR HAPLOTYPE 1 (H1) OF THE GENE CODING FOR THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) |
| Esparza A. |
- |
NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS |
| Espinosa G. |
- |
THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS |
| Esposito G. |
- |
PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG |
| Essayagh S. |
- |
MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM |
| Essers E. |
- |
SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A |
| |
- |
LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA |
| Estellés A. |
- |
PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION |
| |
- |
ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION |
| Estelles A. |
- |
FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS |
| |
- |
ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION |
| |
- |
INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS |
| Estellés A. |
- |
INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE |
| Etherington A. |
- |
IS THE ASSESSMENT OF CLOPIDOGREL RESPONSIVENESS AFFECTED BY THE ANTICOAGULANT OR MEASUREMENT OF MAXIMUM PLATELET AGGREGATION OR FINAL PLATELET AGGREGATION? |
| Ettelaie C. |
- |
THE ABILITY OF TF TO PROMOTE TUMOUR CELL IMMUNE EVASION, MEDIATED VIA SURFACE VCAM-1 |
| |
- |
DIFFERENTIAL EXPRESSION OF TF IN CARDIAC HYPERTROPHY AND ITS INVOLVEMENT IN THE PROGRESSION OF THE DISEASE |
| |
- |
THE INFLUENCE OF TISSUE FACTOR ON OESTROGEN RECEPTOR ALPHA EXPRESSION AND CELL INVASION IN BREAST CANCER CELLS |
| Ettinger R.A. |
- |
C2 DOMAIN T-CELL EPITOPES IN HEMOPHILIA A SUBJECTS WITH THE MUTATION A2201P |
| Eurich D.T. |
- |
POST-THROMBOTIC SYNDROME (PTS) AFTER TOTAL HIP REPLACEMENT (THR): INCIDENCE AND CORRELATES |
| Evangelista V. |
- |
PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION |
| |
- |
GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS |
| |
- |
INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION |
| |
- |
PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO |
| |
- |
PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN |
| |
- |
ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE |
| Evangelisti L. |
- |
GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS |
| |
- |
HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM |
| |
- |
HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES |
| |
- |
ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA |
| |
- |
MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME |
| Evans G. |
- |
WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM |
| |
- |
HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY |
| Evans D. |
- |
REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION |
| Ewenstein B. |
- |
COST-EFFECTIVENESS (CE) OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) VS. RECOMBINANT FVIIA IN PROPHYLAXIS IN HEMOPHILIA PATIENTS WITH INHIBITORS |
| |
- |
HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING MAJOR ORTHOPEDIC SURGERIES: COST-MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) AND RECOMBINANT FVIIA |
| Ewenstein B.M. |
- |
BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER? |
| |
- |
BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE |
| Ewenstein B. |
- |
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION |
| |
- |
ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS) |
| |
- |
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT |
| Ewenstein B.M. |
- |
ASSESSMENT OF THROMBOTIC ADVERSE EVENTS (TAES) WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES (APCCS): 17 YEAR EXPERIENCE |
| Ewing N.P. |
- |
ANAMNESIS IN PATIENTS WITH HEMOPHILIA AND INHIBITORS WHO RECEIVE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES FOR PROPHYLAXIS |
| Exner T. |
- |
HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS |
| |
- |
EFFECT OF SCLEROSANTS ON ANTITHROMBOTIC MECHANISMS, ENDOTHELIAL CELLS AND FIBRINOLYSIS |
| |
- |
DETECTION OF HYPERCOAGULABILITY IN PATIENTS WITH THYROID CANCER |
| Ezban M. |
- |
ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA) |
| |
- |
EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS |
| |
- |
RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B |
| |
- |
EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF A RAPID-ACTING RECOMBINANT FVII ANALOGUE, NN1731, IN HEALTHY MALE SUBJECTS |
| |
- |
CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA |
| |
- |
WHOLE BLOOD CLOTTING TIME (WBCT) COMPARED TO IN VIVO DOSE RESPONSE OF RFVIIA IN FVIII-KO MICE |
| |
- |
HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY |
| |
- |
NN1731, A RFVIIA ANALOGUE, SHOWS HIGH EFFICACY AND FAST ONSET OF ACTION IN A SEVERE TAIL BLEEDING MODEL IN HAEMOPHILIA A MICE |
| |
- |
EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS |
| |
- |
A WHOLE BLOOD CLOTTING METHOD MEASURING EX VIVO EFFECTS OF RFVIIA AND FVIII IN HAEMOPHILIA BLOOD |
